Wagner R D, Krul E S, Tang J, Parhofer K G, Garlock K, Talmud P, Schonfeld G
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110.
J Lipid Res. 1991 Jun;32(6):1001-11.
A new, large kindred with hypobetalipoproteinemia and a previously undescribed truncated form of apolipoprotein B (apoB) has been identified. The asymptomatic, Caucasian male proband (CK, aged 37 years) has total plasma cholesterol, triglyceride, low density lipoprotein-(LDL) cholesterol, high density lipoprotein- (HDL) cholesterol, and apoB concentrations of 108, 131, 32, 50, and 16 mg/dl, respectively. Plasma samples of 11 family members spanning three generations, which had less than 5th percentile concentrations of LDL-cholesterol, contained three apoB bands detected on immunoblots: the normal apoB-100 and apoB-48 and an unusual band of apparent molecular mass of 299,356 +/- 9580 daltons (approximately 54% the molecular weight of apoB-100). Additional immunoblotting experiments using several different anti-apoB monoclonal antibodies showed that the carboxyl terminal of apoB-100 had been deleted somewhere between amino acid residues 2148-2488. A segment of genomic DNA from the proband was amplified by polymerase chain reaction (PCR) between nucleotides 7491-7791 of Exon 26 of the apoB gene. The DNA segment was cloned into pGEM3Zf(-) and sequenced. A C----T transition was found at nucleotide 7665, resulting in a premature stop codon at amino acid residue 2486 corresponding to apoB-54.8. These results were confirmed by direct sequencing of PCR products from three apoB-54.8 positive and three apoB-54.8 negative kindred members. Allele-specific oligonucleotides were used to identify other affected family members. Cosegregation of apoB-54.8 with the C----T transition occurred in all cases. Based on haplotypes constructed from restriction fragment length polymorphism, variable number of tandem repeats, and 5' insertion/deletion analyses and from the presence or absence of apoB-54.8, it was possible to assign a single allele of apoB to the mutation throughout the family. In contrast with other shorter truncations such as apoB-31, apoB-40, and apoB-46, which are found with particles in the HDL density range, and apoB-89 that is found primarily with LDL, apoB-54.8 was found primarily in very low density lipoproteins, much less in LDL, and was virtually absent in HDL. This suggests that the length of the truncation may significantly affect the metabolism of the associated lipoprotein particles.
已鉴定出一个新的、患有低β脂蛋白血症且带有一种此前未描述过的截短形式载脂蛋白B(apoB)的大型家系。无症状的白种男性先证者(CK,37岁)的血浆总胆固醇、甘油三酯、低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇和apoB浓度分别为108、131、32、50和16mg/dl。对三代中11名家族成员的血浆样本进行检测,这些样本的LDL胆固醇浓度低于第5百分位数,免疫印迹检测到三条apoB条带:正常的apoB - 100和apoB - 48以及一条表观分子量为299,356±9580道尔顿(约为apoB - 100分子量的54%)的异常条带。使用几种不同的抗apoB单克隆抗体进行的额外免疫印迹实验表明,apoB - 100的羧基末端在氨基酸残基2148 - 2488之间的某个位置被删除。通过聚合酶链反应(PCR)扩增先证者apoB基因第26外显子核苷酸7491 - 7791之间的一段基因组DNA。将该DNA片段克隆到pGEM3Zf(-)中并进行测序。在核苷酸7665处发现了C→T转换,导致在对应于apoB - 54.8的氨基酸残基2486处出现提前终止密码子。来自三个apoB - 54.8阳性和三个apoB - 54.8阴性家系成员的PCR产物直接测序证实了这些结果。使用等位基因特异性寡核苷酸来鉴定其他受影响的家族成员。在所有病例中,apoB - 54.8与C→T转换共分离。基于由限制性片段长度多态性、可变数量串联重复以及5'插入/缺失分析构建的单倍型,以及apoB - 54.8的存在与否,有可能在整个家族中为该突变指定一个单一的apoB等位基因。与其他较短的截短形式如HDL密度范围内颗粒中发现的apoB - 31、apoB - 40和apoB - 46以及主要在LDL中发现的apoB - 89不同,apoB - 54.8主要存在于极低密度脂蛋白中,在LDL中较少,在HDL中几乎不存在。这表明截短的长度可能会显著影响相关脂蛋白颗粒的代谢。